Mammalian Trim47 has been traditionally linked to oncogenic processes, such as activating NF-κB signaling through its SPRY domain–mediated binding to protein kinase C-ε (PKC-ε), which drives breast cancer proliferation and endocrine resistance (37). This evidence concerns the gene TRIM47 and breast carcinoma.